Introduction
============

Lactic acid bacteria (LAB), used as starters in food fermentations and as probiotics, are regularly ingested in large amount by humans. After their ingestion, these bacteria temporarily co-exist with the complex resident gut microbiota. Emerging evidence suggests that this transient microbiota has an impact on composition and metabolism of the gut microbiota and thus possibly on host health ([@B58]; [@B13]). *Lactococcus lactis* is one of the most widely used LAB in starter cultures for manufacturing dairy fermented products. Besides, several natural isolates have been described with beneficial health properties and recombinant *L. lactis* has been proposed as a delivery vehicle for therapeutic molecules in the gastrointestinal tract (GIT) ([@B6]). Transient colonization of the gut by the ingested bacteria, notably through adhesion to mucus that covers and protects the intestinal epithelium, is expected to favor their beneficial effect on the host. The ability of commensal or pathogenic bacteria to adhere to intestinal mucus glycoconjugates was previously attributed to specific proteins present at the bacterial surface ([@B30]; [@B23]; [@B25]; [@B45]). Although *L. lactis* is not a natural inhabitant of the mammalian GIT, proteins able to bind mucins have also been described. This mini-review gives an overview of the beneficial effects reported for *L. lactis*, the mucus composition and function, the different surface proteins discovered in *L. lactis* and involved in muco-adhesion and the different complementary approaches and tools used to uncover their role.

Beneficial Effects of Lactococci in the Git
===========================================

The main beneficial effects reported for natural or recombinant *L. lactis* strains concern their anti-inflammatory potential, making them as possible therapeutic tools in human intestinal bowel diseases. First, several natural *L. lactis* isolates were shown to possess anti-inflammatory properties in cellular models as well as *in vivo* in mouse models of intestinal colitis ([@B46]; [@B40]; [@B2]). Besides, recombinant *L. lactis* expressing anti-inflammatory molecules (cytokine IL10, anti-oxidant enzymes, or protease inhibitor elafin) efficiently reduce intestinal inflammation symptoms and restore colon homeostasis in mice ([@B4]). Alleviation of food allergic manifestations in sensitized mice was also described for *L. lactis* NCC2287 ([@B62]). Interestingly, a recent study reported that *L. lactis* present in a fermented milk product was able to modulate the gut microbiota in permissive subjects (rats or humans), and this property was correlated with an increased persistence in the GIT ([@B61]).

Mucus and Mucins in the Git
===========================

The mammalian GIT is covered by mucus, a viscoelastic gel that lines and protects the intestinal epithelium, separating it from the lumen content. Mucus functions as a dynamic barrier that is permeable to gasses, water and nutrients, but impermeable to most microorganisms. This substance was long considered to act as a "simple" physical barrier, but is now known to exert other key functions essential for maintaining intestinal homeostasis ([@B25]; [@B48]). Mucus covers the intestinal epithelium to a different extent along the GIT. In lower GIT, the small intestine has only a single layer whereas the colon displays a two-layered mucus ([@B16]). The inner layer is depicted as essentially sterile in contrast with the outer layer which is highly colonized ([@B15]). The main constituents of mucus are mucins, which are produced, stored and released by goblet cells. Mucins are large glycoproteins in which the glycans constitute more than 80% of the molecular mass. The O-linked glycan chains contain 1--20 sugar residues most commonly attached to the protein backbone through serine or threonine with *N*-acetylgalactosamine (GalNAc). The chain is elongated with core structures and two potential backbone regions containing *N*-acetylglucosamine (GlcNAc) and galactose (Gal). Terminal sugars are usually fucose, Gal, GalNAc, or sialic acid residues and both Gal and GlcNAc residues may be sulfated, thus offering a high degree of diversification ([@B39]). MUC2 is the secreted gel-forming mucin present in the intestine ([@B24]). In humans, MUC2 is coated with more than 100 different O-linked glycan chains ([@B33]), which notably differ from those in rodents ([@B57]). Mucin oligosaccharides can serve both as binding sites and energy sources for GIT microbes and the difference in the glycan "preferences" of bacteria was suggested to explain host specificity in terms of microbiota ([@B15]).

*L. lactis* Surface Proteins Involved in Muco-Adhesion
======================================================

The cell wall of Gram positive bacteria is made of a thick peptidoglycan sacculus decorated with other glycopolymers (polysaccharides and teichoic acids) as well as proteins ([@B9]). The cell wall proteins are usually classified based on their mode of attachment to the cell envelope: (i) covalent attachment to peptidoglycan through an LPxTG motif and a sortase A-mediated reaction; (ii) non-covalent binding to cell wall glycopolymers through specific domains (e.g., LysM or SH3 domains); (iii) lipid anchoring in the membrane (lipoprotein); (iv) one or several transmembrane domains.

Among the cell wall proteins, only those protruding at the external surface, that are surface-exposed proteins constituting the surfome ([@B47]), are likely involved in bacterial adhesion to abiotic and biotic surfaces. These proteins can be predicted *in silico* by specific flow scheme such as Surf G+ ([@B3]). At the experimental level, they can be specifically targeted by dedicated proteomic methods such as (i) the "shaving" procedure consisting in proteolytic digestion of surface-exposed proteins on live bacteria and LC-MS/MS identification of released peptides ([@B47]) or (ii) selective labeling with a fluorescent dye followed by 2D gel analysis ([@B37]).

Although *L. lactis* is not a typical inhabitant of the mammalian GIT, several surfaces proteins have been previously identified with the ability to bind to mucus/mucins. Most of them belong to the LPxTG-protein family and are encoded by plasmids. Of note, plasmids significantly contribute to the genetic diversity encountered in the *L. lactis* species ([@B1]), related to its adaptation to different niches (food, plant, or animal) ([@B28]; [@B19]; [@B27]; [@B32]). Thus, whereas the laboratory strains, obtained from dairy strains by plasmid and prophage curing, are considered to have a restricted surface proteome ([@B21]), the *L. lactis* surface pan-proteome is probably much richer and more diverse, constituting a potential reservoir of muco-adhesive factors. The proteins described below are likely contributing to muco-adhesion, either through non-specific hydrophobic interactions with mucus components (aggregation factor AggL, protease PrtP) or specific binding to mucin glycans \[mucus-binding proteins (MUBs), pilins containing "lectin" domains\]. In this latter case, it can be speculated that, in the original ecological niche of *L. lactis*, i.e., plant, these proteins might play a role in binding sugar motifs at the surface of vegetal cells, and these motifs could be shared by mucin sugars ([@B44]).

Mucus-Binding Proteins
----------------------

Mucus-binding proteins are bacterial surface adhesins with typical signal peptide and C-terminal LPxTG motif. They contain (multiple) Mub domains (around 200 residues in length) and/or MucBP domains (Pfam PF06458, around 50 residues), which have been shown to bind mucins ([@B25]). According to structural studies, the Mub domains consist of two modules B1 and B2 with B2 being a MucBP domain ([@B42]; [@B18]). Contrary to the MucBP domain also present in pathogens ([@B50]), the Mub domain is predominantly found in LAB and is highly abundant in lactobacilli of the gut microbiota ([@B5]). The best characterized MUB protein from *Lactobacillus reuteri* endowed with 14 Mub domains ([@B54]) binds mucus via multiple interactions involving terminal sialylated mucin glycans ([@B17]; [@B20]). In *L. lactis* plasmid free laboratory strains IL1403 and MG1363, only one MUB protein with four Mub domains and devoid of signal sequence, is encoded in the chromosome sequence ([@B5]). However, these strains do not exhibit muco-adhesive properties ([@B52]), suggesting that this MUB protein is not expressed or not functional. In contrast, three other MUB proteins found in dairy or vegetal strains were shown to contribute to bacterial adhesion to mucins as tested by different methods and tools (**Table [1](#T1){ref-type="table"}**). These three proteins have different structures (**Table [1](#T1){ref-type="table"}**), with three MucBP domains in MbpL protein from dairy *L. lactis* BGKP1 ([@B31]), two Mub domains in Muc protein from vegetal *L. lactis* TIL448 ([@B44]) and one MucBP domain in AJ89_07570 protein from dairy *L. lactis* IBB477 ([@B51]).

###### 

Surface proteins identified as responsible for muco-adhesive properties in different natural *L. lactis* strains and corresponding adhesion tests used to probe adhesion to mucus or mucins.

  Protein (length)                                            Characteristics                        Adhesion test                                                           Reference
  ----------------------------------------------------------- -------------------------------------- ----------------------------------------------------------------------- -----------
  ***L. lactis* subsp. *lactis* BGKP1 (dairy)**                                                                                                                              
  **MbpL**                                                    Signal peptide                         *In vitro*: pig gastric mucin in microtiter plate                       [@B31]
  (998 a.a.)                                                  LPxTG motif                            *In vitro*: HT29-MTX intestinal epithelial cell line (muco-secreting)   [@B41]
  (plasmid)                                                   Three MucBP domains                                                                                            
                                                                                                                                                                             
  **AggL**                                                    Signal peptide                         *In vitro*: pig gastric mucin in microtiter plate                       [@B31]
  (1767 a.a.)                                                 LPxTG motif                            *Ex vivo* colonic mucus                                                 [@B41]
  (plasmid)                                                   Four Collagen_bind domains (PF05737)   *In vivo* in rat                                                        
                                                              Six CnaB domains (PF05738)                                                                                     
                                                                                                                                                                             
  ***L. lactis* subsp. *lactis* TIL448 (NCDO2110) (plant)**                                                                                                                  
  **Muc**                                                     Signal peptide                         *In vitro*: pig gastric mucin by AFM                                    [@B44]
  (1130 a.a.)                                                 LPxTG motif                            *In vitro*: pig gastric mucin in shear stress flow chamber              [@B35]
  (plasmid)                                                   Two Mub domains                                                                                                
                                                                                                                                                                             
  **Pili**                                                    Signal peptide                         *In vitro*: pig gastric mucin by AFM                                    [@B44]
  (Tip pilin)                                                 LPxTG motif                            *In vitro*: pig gastric mucin in shear stress flow chamber              [@B35]
  (817 a.a.) (plasmid)                                        *Lectin_legB* domain                                                                                           
                                                                                                                                                                             
  ***L. lactis* subsp. *cremoris* IBB477 (dairy)**                                                                                                                           
  **AJ89_07570**                                              Signal peptide                         *In vitro*: pig gastric mucin in microtiter plate                       [@B51]
  (956 a.a.)                                                  One DUF285 domain                                                                                              
  (chromosome)                                                One MucBP domain                                                                                               
                                                              Four Big_3 domains                                                                                             
                                                                                                                                                                             
  **PrtP**                                                    Signal peptide                         *In vitro*: pig gastric mucin in microtiter plate                       [@B52]
  (1960 a.a.)                                                 LPxTG motif                            *In vitro*: HT29-MTX intestinal epithelial cell line (muco-secreting)   
  (plasmid)                                                                                          *In vivo* in mice                                                       

The different adhesion tests are schematically presented in

Figure
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Pili
----

Pili are elongated protein structures of 1--10 nm in diameter and a few μm in length, protruding outside bacterial cells. They were long considered as characteristic of pathogens ([@B12]) but have been later discovered in LAB, in probiotic *Lactobacillus rhamnosus* GG, where they bind human mucins and could explain the strain persistence in human GIT ([@B26]). Pili were also described in *L. lactis*. Until now, three different gene clusters specifying sortase-dependent heterotrimeric pili have been identified in several *L. lactis* strains, one chromosomal present in all *L. lactis* strains ([@B49]) and two plasmid-encoded others in plant ([@B44]) and dairy ([@B56]) strains respectively. These gene clusters encode three pilins, the major pilin which is polymerized by the sortase C to form the pilus backbone, a minor anchoring pilin and a tip pilin usually endowed with adhesive properties, as well as sortase C ([@B43]; [@B22]). After synthesis, pili are covalently anchored to peptidoglycan by sortase A ([@B14]). Noteworthy, the three identified *L. lactis* pili gene clusters exhibit limited sequence identity and have different syntheny. The chromosomal pilus gene cluster studied in the laboratory strain IL1403, as well as the plasmid one in *L. lactis* NCDO712 dairy strain, are not expressed in standard conditions but overexpression allowed pili synthesis ([@B49]; [@B56]). In contrast, in the plant isolate *L. lactis* TIL448, the synthesis of pili at the bacterial surface was revealed without overexpression, by a proteomic analysis with the "shaving" approach and the presence of pili was visualized by electron microscopy and atomic force microscopy (AFM). These pili were further shown to contribute, together with the protein Muc, to mucin specific binding (**Table [1](#T1){ref-type="table"}**). Interestingly, the tip pilin is a large protein with an LPxTG motif and containing a lectin domain (PF00139, *Lectin_legB* domain) that could recognized mucin glycan ([@B44]). Pili were also visualized by electron microcopy in four other *L. lactis* plant or clinical natural isolates but the genes involved in their synthesis were not identified ([@B49]).

Aggregation Factor AggL
-----------------------

A plasmid-encoded aggregation factor, AggL, was characterized in *L. lactis* BGKP1. It is a cell-wall anchored protein with a LPxTG motif and seven collagen-binding protein B domains (CnaB domain) and it is responsible for cell surface hydrophobicity and bacterial aggregation phenotype ([@B31]). It was shown to contribute to mucus adhesion (**Table [1](#T1){ref-type="table"}**), probably as a result of non-specific hydrophobic interactions with the hydrophobic mucosal surface ([@B41]).

Cell Wall Protease PrtP
-----------------------

The cell-wall anchored proteinase, PrtP, has a crucial role in milk casein degradation required for efficient growth of *L. lactis* in milk ([@B55]). The presence of PrtP at the surface of *L. lactis* was shown to modify the cell surface physico-chemical properties, leading to a greater hydrophobicity and increased adhesion to abiotic surfaces ([@B21]). In *L. lactis* IBB477, the cell surface PrtP was shown to contribute to mucin adhesion ([@B52]) (**Table [1](#T1){ref-type="table"}**).

Tools to Decipher the Role of *L. lactis* Surface Proteins in Muco-Adhesion
===========================================================================

The different tools and methods used until now to probe adhesion of *L. lactis* to mucus/mucins are summarized in **Figure [1](#F1){ref-type="fig"}**.

![Schematic representation of methods and tools used to probe muco-adhesion of *Lactococcus lactis* (AFM, atomic force microscopy; QCM-D, quartz crystal microbalance with dissipation monitoring; SSFC, shear stress flow chamber). For the sake of clarity, schemes are not to scale.](fmicb-08-02247-g001){#F1}

*In Vitro* Models
-----------------

*In vitro* models that are most commonly used for evaluation of *L. lactis* adhesive properties, involve static microtiter plate assays using immobilized commercially available mucin (pig gastric mucin, PGM) and/or gut-related epithelial cell lines (**Figure [1](#F1){ref-type="fig"}**). Adherent bacterial cells are quantified using various approaches such as culturing/microscopical enumeration ([@B29]; [@B44]), radiolabeling ([@B53]), crystal violet staining ([@B41]; [@B51]), or FISH ([@B52]). The two most commonly used intestinal epithelial cell lines to study LAB adhesion are Caco-2 and HT29, which are originally derived from a human colorectal adenocarcinoma. Their major disadvantage is the lack of substantial mucus production. However, a mucus-secreting subpopulation of goblet cells from HT29 cell population (HT29-MTX) has been obtained after growth adaptation of HT29 cells to anticancer drug methotrexate (MTX) ([@B38]) and this cell line is increasingly used to investigate the muco-adhesive properties of *L. lactis* ([@B41]; [@B52]).

Biophysics-Based Concepts and Tools
-----------------------------------

Biophysics-based tools have provided new *in vitro* insights into the interaction mechanisms between *L. lactis* and mucins (**Figure [1](#F1){ref-type="fig"}**). Interaction forces were quantified at nanoscale by AFM force spectroscopy using a *L. lactis-*functionalized tip ("lacto-probe") and PGM-coated surface ([@B11]). Both non-specific and specific forces (ligand/receptor bonding) were at play in *L. lactis* adhesion to PGM. For *L. lactis* IBB477, the percentage of specific adhesive events was high (20%), in comparison with its low-adhesive counterpart *L. lactis* MG1820 (about 5%) ([@B34]). Furthermore, mucin oligosaccharides were essential in interactions between *L. lactis* and PGM, as shown with blocking assays. For the first time with living cell probes and mucin, specific interactions were analyzed through kinetic constants: (i) the kinetic dissociation constant K~off~ was determined with increasing the tip loading rate, which led to a higher adhesion force. The K~off~ value (0.46 s^-1^) was consistent with values corresponding to sugar/protein interactions ([@B34]); (ii) the kinetic association constant K~on~ (3.3 × 10^2^ M^-1^ s^-1^) was deduced from enhancing the tip/sample contact time. Furthermore, the high adhesion of IBB477 *vs.* MG1820 to PGM was confirmed at the multicellular level and under flow field conditions, using real-time quartz crystal microbalance with dissipation monitoring (QCM-D) ([@B36]) and shear stress flow chamber ([@B51]). Later studies revealed the combined contribution of chromosomal and plasmid-encoded cell-wall proteins (MucBP-Big_3 containing protein and proteinase PrtP respectively) in the muco-adhesive properties of IBB477 ([@B51], [@B52]).

A further work on the plant isolate *L. lactis* TIL448 enabled to elucidate the *L. lactis* muco-adhesive phenotype, based on the respective contribution of pili and MUB protein ([@B35]). With AFM force spectroscopy, a high proportion of specific adhesive events to PGM was detected (60%), consistent with the weak shear-flow induced detachment of bacterial cells from the PGM coating. Rupture events were observed in AFM at short (100--200 nm) and long distances (up to 600--800 nm). With AFM force spectroscopy on pili and MUB protein defective mutants, the equivalent role exerted by these two cell surface determinants was established. However, under shear flow, a more critical contribution of MUB protein than pili was found. The importance of pili was further dissected in relation with their nanomechanical properties as probed with optical tweezer ([@B7],[@B8]). AFM blocking assays also revealed that mucin neutral oligosaccharides were involved in adhesion of *L. lactis* TIL448 to PGM ([@B35]).

*In Vivo* Animal Models
-----------------------

A relatively low number of *in vivo*/*ex vivo* studies (i.e., biopsy samples) have been conducted to confirm the muco-adhesive phenotype of *L. lactis* in "real" environmental conditions (**Figure [1](#F1){ref-type="fig"}**). Application of such methods seems to be the next step, as shown for lactobacilli ([@B10]; [@B59]). Nevertheless, first experimental evidence has been provided for lactococci. In mice, the GFP-labeled *L. lactis* WH-C1 strain was found to adhere to the gut mucosa ([@B60]). In another study in rats, in *ex vivo* and *in vivo* experiments, AggL protein was found to confer adhesive properties to *L. lactis* BGKP1 to colonic tissue through non-specific hydrophobic interactions. In contrast, for this particular strain, the MbpL protein did not contribute to bacterial adhesion to colonic tissues but was rather involved in gastric mucin binding ([@B41]). More recently, it was shown that the cell-wall proteinase PrtP, albeit contributing to *in vitro* muco-adhesion of *L. lactis* IBB477, probably through non-specific interactions, could not confer a selective advantage to this strain in the gut of conventional C57BL/6 mice ([@B52]).

Conclusion
==========

Certain *L. lactis* strains synthesize surface proteins with muco-adhesive properties. Although *L. lactis* is not a natural inhabitant of the mammalian GIT, the main classes of bacterial adhesins, i.e., MUB proteins and pili, allowing mucin glycan recognition, are encoded in the pangenome of the *L. lactis* species, which includes numerous plasmids. In commensal lactobacilli, MUB proteins and pili promote host mucosae colonization, while in *L. lactis* in its original ecological niche these proteins might rather play a role in plant tissue colonization. Nevertheless, the lactococcal pangenome appears as a reservoir of novel functions for beneficial gut-targeted activity. Indeed, muco-adhesive *L. lactis* strains will probably display an augmented fitness in the host GIT, favoring transient colonization, and thus potentially promoting health benefits. Until now, *L. lactis* muco-adhesion has been mainly studied *in vitro* with a wide range of tools and approaches on PGM and HT29-MTX cells, that should be completed in the future with *in vitro* studies on human intestinal mucins and *in vivo* studies.
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